Anteris Technologies Announces $20M Private Placement with Perceptive Advisors BRISBANE, Australia and EAGAN, Minn., March 02, 2022 (GLOBE NEWSWIRE) -- Anteris Technologies Ltd (Anteris or the Company) Limited (ASX: AVR) announces the Company has entered a binding agreement to...

Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference BRISBANE, Australia and EAGAN, Minn., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Anteris Technologies Ltd (ASX:AVR) (Anteris or the Company), a structural heart company advancing its novel DurAVR™ valve for...

Anteris Technologies to Present at Credit Suisse Structural Heart Forum on November 23, 2020 BRISBANE, Australia and EAGAN, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) --  Anteris Technologies Ltd (ASX:AVR) (Anteris or the Company), a structural heart company advancing its novel DurAVR™ valve for...

Anteris Technologies to Host TAVR Key Opinion Leader Symposium Moderated by Matt Miksic of Credit Suisse on July 20th, 2020 BRISBANE, Australia and EAGAN, Minn., July 09, 2020 (GLOBE NEWSWIRE) -- Anteris Technologies Limited (ASX:AVR), a structural heart company advancing the DurAVR™ valve, a novel aortic valve...

Admedus Changes Name to Anteris Technologies Ltd BRISBANE, Australia and EAGAN, Minn., June 01, 2020 (GLOBE NEWSWIRE) -- Admedus Limited (ASX: AHZ), announced today that it has changed the Company’s name to Anteris Technologies Ltd (“Anteris”). As...